L-Dopa in Parkinsonism and the Influence of Previous Thalamotomy

No abstract is available for this paper.

• Publication year

  1971

• Venue

  British medical journal

• Publication date

  1971-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.1.5739.7PMID 4923653PMCID PMC1794736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

  1998cited by this paper
• Prolonged Exposure: a Rapid Treatment for Phobias

  1971influential reference
• Importance and pathogenesis of abnormal movements during L-dopa therapy of Parkinson's disease.

  1970cited by this paper
• Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane.

  1970cited by this paper
• Treatment of Parkinsonism with Laevo-Dopa

  1970cited by this paper
• L-dopa in the treatment of Parkinsonism; a preliminary appraisal.

  1970cited by this paper
• Reversal of the glabellar reflex in Parkinsonism by L-dopa.

  1969cited by this paper
• Modification of Parkinsonism--chronic treatment with L-dopa.

  1969cited by this paper
• Treatment of parkinsonism with levodopa.

  1969cited by this paper
• Effects of L-dopa in Parkinson's disease.

  1969cited by this paper
• L-dopa in postencephalitic parkinsonism.

  1969cited by this paper
• Aromatic amino acids and modification of parkinsonism.

  1967cited by this paper
• Dopamine metabolism in Parkinson's disease

  1963cited by this paper
• The pathogenesis of Parkinson's disease: a new hypothesis.

  1962cited by this paper
• [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

  1961cited by this paper
• On the presence of 3-hydroxytyramine in brain.

  1958cited by this paper
• 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists

  1957cited by this paper

• Scalable Asymmetric Syntheses of Foslevodopa and Foscarbidopa Drug Substances for the Treatment of Parkinson's Disease.

  2021cites this paper
• Clinical Trials in Psychiatry

  2018cites this paper
• Thalamic Stimulation for Parkinson’s Disease: Clinical Studies on DBS

  2015cites this paper
• Levodopa: A Review of its Pharmacological Properties and Therapeutic Uses with Particular Reference to Parkinsonism

  2012cites this paper
• Neurobehavioural deficits following postnatal iron overload: I spontaneous motor activity

  2009cites this paper
• The long-term results of stereotaxie surgery and L-dopa therapy in patients with Parkinson ' s disease A 10-year follow-up study

  2009cites this paper
• Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice

  2009cites this paper
• The use of thalamotomy in the treatment of levodopa-induced dyskinesia

  2005cites this paper
• Treatment of Parkinson's syndrome with l-DOPA on an out-patient basis

  2004cites this paper
• Treatment of Parkinson's disease with l-DOPA and decarboxylase inhibitor

  2004cites this paper
• Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration.

  2003cites this paper
• Functional alteration by NMDA antagonist: Effects of L-Dopa, neuroleptics drug and postnatal administration

  2002cites this paper
• Restorative effects of glutamate antagonists in experimental parkinsonism

  2002cites this paper
• Surgical therapies for Parkinson's disease. A physician's perspective.

  2001cites this paper
• CT-Guided Unilateral Thalamotomy with Macroelectrode Mapping for the Treatment of Parkinson's Disease

  2001cites this paper
• Surgery for levodopa-induced dyskinesias.

  2000cites this paper
• Surgical treatment of Parkinson's disease.

  1999cites this paper
• Surgical treatment options in Parkinson's disease.

  1998cites this paper
• [Neurosurgical methods in treatment of Parkinson disease. Current status].

  1997cites this paper
• Posteroventral pallidotomy: its effect on motor symptoms and scores of MMPI test in patients with Parkinson's disease.

  1997cites this paper
• Neurochirurgische Verfahren zur Behandlung des Morbus Parkinson Eine Bestandsaufnahme*

  1997cites this paper
• Contribution of Human Stereotaxic Surgery to Treatment and Understanding of Parkinson’s Disease

  1996cites this paper
• Ventrolateral thalamotomy for dyskinesia following levodopa therapy of Parkinson's disease.

  1996cites this paper
• Efficacy and safety of stereotaxic surgical treatment of tremor disorders

  1996cites this paper
• The neural mechanisms and progressive nature of symptoms of Parkinson's disease—based on clinical, neurophysiological and morphological studies

  1995cites this paper
• Transient resolution of bilateral tremor after unilateral thalamotomy, associated with focal injury of the corpus callosum: case report.

  1995cites this paper
• Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease.

  1993cites this paper
• Thalamotomy in parkinsonism

  1992cites this paper
• Blinded evaluation confirms long‐term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease

  1992cites this paper
• Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus.

  1992cites this paper
• [Orthostatic dysregulation in Parkinson syndrome. Results of a study of 250 patients].

  1990cites this paper
• Study of the neural pathways concerned with involuntary movements induced by electrical stimulation of the mesencephalic ventromedial tegmentum in cats

  1989cites this paper
• Long-term follow-up study of nucleus ventralis intermedius and ventrolateralis thalamotomy using a microelectrode technique in parkinsonism.

  1987cites this paper
• The place of thalamotomy in the treatment of parkinsonism.

  1987cites this paper
• Basal ganglia and Parkinson's disease: neurobiological and pharmacological aspects in animals and man.

  1984cites this paper
• Levodopa-induced dyskinesia and thalamotomy.

  1984cites this paper
• Diagnosis and management of parkinsonism in the elderly.

  1983cites this paper
• Clinical trials in psychiatry

  1983cites this paper
• Clinical trials in psychiatry.

  1983cites this paper
• Study of the neural pathway concerned with the non-rhythmic involuntary movements in cats

  1983cites this paper
• The management of Parkinson's disease.

  1982cites this paper
• Effects of Adrenergic Activators and Inhibitors on the Skeletal Muscles

  1981cites this paper
• Speech disorders of Parkinsonism: a review.

  1981cites this paper
• Clinical analysis of akinesia.

  1980cites this paper
• The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease. A 10-year follow-up study.

  1980cites this paper
• Neurophysiological study of the extrapyramidal system in cats

  1980cites this paper
• The treatment of Parkinson's disease.

  1977cites this paper
• Effect of thalamotomy and levodopa therapy on the speech of Parkinson patients.

  1977cites this paper
• Letter: Effect of levodopa on Parkinsonian tremor.

  1976cites this paper
• Management of parkinson's disease--combined therapy with levodopa and thalamotomy.

  1975cites this paper
• [Changes of blood pressure, pulse and electrolytes following long-term treatment of Parkinsonism using Ro 8-0576 (L-Dopa and decarboxylase inhibitor)].

  1975cites this paper
• L-Dopa and the treatment of extrapyramidal disease.

  1975cites this paper
• [Therapy of Parkinsonian syndrome using L-dopa. Current state and problems].

  1974cites this paper
• Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa.

  1974cites this paper
• Long-term treatment of Parkinson's disease with levodopa.

  1974cites this paper
• [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

  1974cites this paper
• Zur differentiellen Therapie des Morbus Parkinson unter besonderer Berücksichtigung von iatrogenen Schädigungsmöglichkeiten

  1974cites this paper
• LEVODOPA FOR PARKINSONISM IN ELDERLY AND DEMENTED PATIENTS

  1973cites this paper
• Early and late effects of levodopa on the cardiovascular system in Parkinson's disease. A paired study.

  1973cites this paper
• The patient's view of L-Dopa after one year's therapy.

  1973cites this paper
• SLOWLY ABSORBED L‐DOPA PREPARATION IN THE TREATMENT OF PARKINSONISM

  1973cites this paper
• LEVODOPA IN PARKINSON'S DISEASE—AUSTRALIAN COLLABORATIVE TRIAL

  1973cites this paper
• A qualitative and quantitative evaluation of parkinsonians three to six years following thalamotomy.

  1973cites this paper
• Stereotactic thalamotomy and L-dopa induced involuntary movement in Parkinsonism.

  1973cites this paper
• Levodopa and amantadine in the treatment of Parkinsonism.

  1972cites this paper
• The comparative value of amantadine and levodopa

  1972cites this paper
• Thirty months' trial of levodopa in Parkinson's disease

  1972cites this paper
• Recent advances in the treatment of Parkinsonism with drugs.

  1972cites this paper
• Catecholamine Synthesis and Metabolism in Man: Clinical Implications (With Special Reference to Parkinsonism)

  1972cites this paper
• Levo-dihydroxyphenylalanine--Parkinson's disease and manganese poisoning.

  1972cites this paper
• The management of Parkinson's syndrome.

  1972cites this paper
• THERAPEUTIC GUIDELINES AND SIDE EFFECTS ENCOUNTERED DURING L‐DOPA THERAPY IN 100 CASES OF PARKINSONISM

  1971cites this paper
• Effect of Age and Arteriosclerosis on the Response of Parkinsonian Patients to Levodopa

  1971cites this paper
• Levodopa for parkinsonism.

  1971cites this paper
• SERIAL DETERMINATIONS OF HOMOVANILLINIC ACID IN THE CEREBROSPINAL FLUID OF PARKINSON PATIENTS TREATED WITH L‐DOPA

  1971cites this paper
• Levodopa in Parkinsonism: the Effects of Withdrawal of Anticholinergic Drugs

  1971cites this paper
• Parkinson ' s disease . tremor and levodopa induced dyskinesias in Chronic thalamic stimulation improves

  year unknowncites this paper